GRM2 and neuroblastoma: We tested the cell viability activity of the metabolite of Revefenacin, THRX-195518, in comparison to the effects of the mGlu II orthosteric agonist, LY 379268, and mGlu2 PAM, JNJ-46281222 in the human neuroblastoma SH-SY5Y cell line damaged by Glu.